CLEAR CARE PLUS CLEANING AND DISINFECTING SOLUTION

Riik: Kanada

keel: inglise

Allikas: Health Canada

Toimeaine:

HYDROGEN PEROXIDE

Saadav alates:

ALCON CANADA INC

ATC kood:

S01XA20

INN (Rahvusvaheline Nimetus):

ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.

Annus:

3%

Ravimvorm:

SOLUTION

Koostis:

HYDROGEN PEROXIDE 3%

Manustamisviis:

DISINFECTANT (Contact Lens)

Ühikuid pakis:

90/360/480ML

Retsepti tüüp:

OTC

Terapeutiline ala:

CONTACT LENS SOLUTIONS

Toote kokkuvõte:

Active ingredient group (AIG) number: 0106899001; AHFS:

Volitamisolek:

CANCELLED POST MARKET

Loa andmise kuupäev:

2020-12-10

Toote omadused

_ _
_CLEAR CARE* PLUS Cleaning and Disinfecting Solution _
_Page 1 of 22_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
CLEAR CARE* PLUS
CLEANING AND DISINFECTING SOLUTION
3% Hydrogen Peroxide
Professed Standard
Contact Lens Disinfectant
Alcon Canada Inc.
2665 Meadowpine Blvd.
Mississauga, ON, L5N 8C7
Date of Preparation:
December 11, 2015
Date of Revision:
Submission Control No: 177795
*a Trademark of Novartis
©2015 Novartis
_ _
_CLEAR CARE* PLUS Cleaning and Disinfecting Solution _
_Page 2 of 22_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
..............................................................7
STORAGE AND STABILITY
............................................................................................9
SPECIAL HANDLING INSTRUCTIONS
.........................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................9
PART II: SCIENTIFIC INFORMATION
............................................................